Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 7,144 shares at $1.83 ($13K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Scheduled sale ($13k) by SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $13K | — | Filing → |